Pharm D Solutions, LLC recalls Bi-Mix (Papaverine/Phentolamine 150 mg/5 mg) a) Injectable NDC 69699-1760-15; b) (LYO) Powder NDC 69699-1760-15, Pharm D
Recalled November 7, 2018 · FDA recall D-0144-2019 · Pharm D Solutions
Hazard
Lack of Assurance of Sterility · FDA Class II
Units
29 vials
Sold at
Nationwide
Description
Lack of Assurance of Sterility
Product
Bi-Mix (Papaverine/Phentolamine 150 mg/5 mg) a) Injectable NDC 69699-1760-15; b) (LYO) Powder NDC 69699-1760-15, Pharm D Solutions, Houston, Texas
Manufacturer(s)
Pharm D Solutions, LLC
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →